Voraxaze for Delayed Methotrexate Clearance

NCT00424645 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Sponsor terminated due to low accrual.

Conditions

Hematologic Malignancy
Solid Tumor

Interventions

DRUG: Voraxaze (Glucarpidase)
DRUG: Placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]